LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Lantern Pharma Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.64−0.03 (-4.05%)
Close on Oct 19, 2026
- Market cap
- $7.97M
- P/E (TTM)
- –
- Dividend yield
- –
Lantern Pharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Market Cap | $8.20M | $166.30M |
| Enterprise Value | $837.22K | $88.19M |
Income (trailing twelve months)
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Operating Income | -$15.47M | -$21.40M |
| Net Income | -$18.65M | -$22.46M |
| EBITDA | -$15.45M | -$16.91M |
| EPS (Diluted) | -$1.62 | -$0.83 |
Returns
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Return on Equity (ROE) | -400.9% | -53.2% |
| Return on Assets (ROA) | -143.4% | -40.9% |
| Return on Capital Employed (ROCE) | -361.4% | -38.1% |
Balance sheet
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $7.36M | $61.43M |
| Net Cash (Debt) | $7.36M | $15.35M |
| Net Cash Per Share | $0.58 | $0.66 |
| Equity (Book Value) | -$3.22M | $49.09M |
| Book Value Per Share | -$0.25 | $1.37 |
| Tangible Book Value | -$3.22M | $23.52M |
| Working Capital | $4.14M | $76.81M |
Financial position
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Current Ratio | 1.96 | 3.34 |
| Quick Ratio | 1.70 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$14.08M | -$12.35M |
Efficiency
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Profits Per Employee | -$1.17M | -$703.34K |
| Employee Count | 16 | 74 |
Dividends and yields
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Earnings Yield | -227.5% | -23.3% |
Shares
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Shares Outstanding | 12,784,100 | 58,127,000 |
| Shares Change (YoY) | 5.99% | 10.9% |
| Shares Change (QoQ) | 13.4% | 0.54% |
| Float | 10,191,200 | 49,136,700 |
| Shares Held by Insiders | 20.3% | 11.6% |
| Shares Held by Institutions | 22.6% | 59.4% |
Scores
| Measure | Lantern Pharma | Industry median |
|---|---|---|
| Altman Z-Score | -21.79 | -0.22 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Lantern Pharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.